Citation

Nasrallah HA. Curr. Psychiatr. 2012; 11(7): 14-15.

Copyright

(Copyright © 2012, Frontline Medical Communications)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; ketamine; cause of death; suicide attempt; major depression; serotonin; article; antidepressant agent; disease association; serotonin uptake inhibitor; tricyclic antidepressant agent; unclassified drug; noradrenalin; dopamine; nonhuman; medical research; drug efficacy; drug effect; corticotropin releasing factor antagonist; drug response; remission; cytokine; outcome assessment; brain derived neurotrophic factor; phosphodiesterase inhibitor; neuropeptide Y; drug design; drug targeting; serotonin noradrenalin reuptake inhibitor; cannabinoid 1 receptor antagonist; hormone receptor stimulating agent; glycine; histone deacetylase inhibitor; glucocorticoid antagonist; tissue plasminogen activator; alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid; cannabinoid 1 receptor agonist; fibroblast growth factor; galanin; glucocorticoid agonist; kappa opiate receptor antagonist; melatonin receptor agonist; vasculotropin; vasopressin receptor antagonist